Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) just unveiled an update.
Recordati S.p.A. has announced an update on its share buyback program initiated on April 30, 2025. The company purchased 89,225 shares between May 19 and May 23, 2025, at an average price of 51.3752 Euros per share. This buyback is part of Recordati’s strategy to allocate shares for stock option and performance share plans for its management, reflecting its commitment to incentivizing its leadership and enhancing shareholder value.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company offers therapeutic options in specialty and general medicine, as well as rare diseases, and is involved in clinical development, production, marketing, and licensing of chemical and finished products. Recordati operates in about 150 countries across the EMEA, Americas, and APAC regions, employing over 4,580 people.
Average Trading Volume: 430,211
Technical Sentiment Signal: Buy
Current Market Cap: €10.6B
See more data about REC stock on TipRanks’ Stock Analysis page.